Schedule 13D ownership disclosure

SCINAI IMMUNOTHERAPEUTICS LT

Security class unavailable · CUSIP: 09073Q204

Event date: 2024-03-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
624,000
Percent of class
12.9600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000912282-24-000243
Form type
SC 13D
Filer
STONE DANIEL E.
CIK
CIK 1948744
Filed
Mar 12, 2024
Reporting period
Mar 12, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub